NCT00441519View on ClinicalTrials.gov

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Healthy
Interventions
DRUG

aspirin

DRUG

omeprazole

Trial Locations (2)

27517

POZEN, Chapel Hill

H4R2N6

MDS Pharma Services, Montreal

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00441519 - A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin | Biotech Hunter | Biotech Hunter